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Abstract Febrile seizures (FSs) are the most common form
of childhood seizures. The higher levels of pro-inflammatory
cytokines in children may induce seizures, and alternatively,
higher levels of anti-inflammatory cytokines may act as a
defense mechanism against seizures. We aimed to investigate
whether interleukin (IL)-1β-511 C/T (pro-inflammatory cyto-
kine) (rs16944) and IL-1 receptor antagonist (IL-1Ra) (an
anti-inflammatory cytokine) gene polymorphisms could be
used as markers for prediction of susceptibility to FSs. The
current study included 22 patients with FSs and 22 normal
control subjects. All patients were subjected to thorough his-
tory taking, full neurological examination, electroencephalog-
raphy, and peripheral blood sampling for genotype analyses.
Detection of IL-1Ra gene polymorphisms was done using
polymerase chain reaction (PCR), while a restriction fragment
length polymorphism analysis of the PCR products was used
for the detection of IL-1β-511 C/T gene polymorphisms. The
mean age of onset of first febrile seizures was 15.7 months.
Eighteen (81.8 %) cases had the criteria of complex FSs.
Frequencies of alleles C and T for IL-1β-511 were 26/44
and 18/44, respectively, in FS patients and 22/44 for both in
the control subjects. The CC genotype was significantly more
common in the FS patients than in the control group. The
IL-1Ra-I homozygote was more frequent in patients with FSs
than in healthy controls. The IL-1Ra homozygous I/I and
IL-1β-511 CC gene polymorphisms are associated with a
higher susceptibility to febrile seizures, which may be useful
markers for predicting the development of febrile seizures.
Keywords Febrile seizures . Interleukin-1 receptor
antagonist . Interleukin-1beta-511
Introduction
Febrile seizures (FSs) are the most common convulsive
event in children before the age of 5 years, with both boys
and girls being equally affected (Serdaroglu et al. 2009). FSs
occur in 2 to 5 % of infants in Europe and North America
and 6–9 % in Japan (Hauser 1994).
An FS is defined by the International League Against
Epilepsy as a seizure in association with a febrile illness in
the absence of a central nervous system infection, acute
electrolyte imbalance, or any other acute neurological
insults in children older than 6 months of age without prior
afebrile seizures (Chou et al. 2010). The pathogenesis of
febrile convulsions remains obscure. In fact, febrile seizures
of children involve a complex interaction between the
immune-inflammatory process, cytokine activation, and ge-
netic factors (Tsai et al. 2002). Twin and family studies
suggest that genetic factors may have an important effect
on predisposition to febrile seizures. This underlying genetic
predisposition, along with the association of fever with the
seizures, suggests that some genes for the regulation of
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inflammatory processes and fever may play a role in the
molecular pathogenesis of FSs (Tsuboi and Endo 1991;
Berkovic et al. 1998; Haspolat et al. 2002). Cytokines are
produced by peripheral monocytes and also by astrocytes and
glial cells within the central nervous system (Tutuncuoglu et
al. 2001). Interleukin 1 (IL-1) is the most important cytokine
inducing fever. The action of endogenous IL-1 in the brain
during fever is site-specific, with roles in the anterior hypo-
thalamus, hypothalamic nucleus, and hippocampus. The
genes of the IL-1 complex, which are located on chromosome
2q13, encode for three proteins: IL-1α, IL-1β, and IL-1
receptor antagonist (IL-1Ra). Each of the genes is poly-
morphic, and there is evidence that certain alleles are associ-
ated with susceptibility to inflammation (Serdaroglu et al.
2009). A single nucleotide polymorphism has been identified
at bp position −511 in the promoter region of the IL-1 β gene
(Kira et al. 2005). The IL-1Ra gene has a penta-allelic poly-
morphic site in intron 2 containing variable numbers of an
86-bp tandem repeat sequence. IL-1RA binds to the IL-1
receptor that inhibits IL-1 α and IL-1 β binding. Because
the effect of IL-1 β is countered by its endogenous antagonist
IL-1RA, it is also considered to have an important role in
inflammation (Serdaroglu et al. 2009). The underlying genetic
predisposition and the association of fever with the seizures
suggest that some genes responsible for the regulation of the
inflammatory process and fever play a role in the molecular
pathogenesis of FSs (Chou et al. 2010).
Aim
The aim of this study is to determine whether interleukin-1beta-
511 promoter polymorphism (IL-1β-511 C/T) and IL-1Ra gene
polymorphisms contribute to the susceptibility of FSs.
Subjects and methods
This study enrolled 22 Egyptian children (18 males and 4
females; age 2.62±1.15 years, mean±SD) diagnosed in the
Pediatric Neurology subdivision of FayoumUniversity Teach-
ing Hospital, fromAugust 2010 till September 2011, as having
febrile seizures. Twenty-two children, gender matched with
cases, were assigned into the control group. They were
recruited from outpatient clinic with negative history of any
type of convulsions or any of the neurological disorders and
living in Fayoum City, Egypt. The control subjects had no
history of seizures or neurological disorders and were chosen
from children older than 7 years of age, to lower the risk of
febrile seizures during the study period. An informed consent
was obtained from all parents of the patients and controls who
donated their blood. The present study was approved by the
Ethical Committee of Fayoum University Teaching Hospital.
Inclusion criteria were: patients aged 12 months to
6 years, the age of onset of the first febrile seizures ranged
from 6 to 36 months, suffering from either simple (typical)
febrile convulsion (fever with generalized tonic–clonic fit
lasting less than 15 min and does not recur in the next 24 h),
or complex (atypical) febrile convulsions (focal seizures
lasting more than 15 min and recur in the same illness),
and with complete normal neurological development. Ex-
clusion criteria were: cases who had history of intracranial
infections, cases diagnosed as cerebral palsy, cases with
delayed motor or mental development, cases with previous
attacks of afebrile seizures, and those who had FSs beyond
6 years which is known as febrile seizures plus.
All patients were subjected to thorough history taking
focusing on the characteristics of FSs as regards the type,
age of onset of seizures, duration, frequency, and a history
of antiepileptic drug intake. The recruited patients were
subjected to thorough general and full neurological exami-
nation and electroencephalography (EEG). All children un-
derwent peripheral blood sampling for genotype detection.
Digital EEG
All patients were subjected to digital EEG at the Neuro-
Pediatric Unit of Pediatric Department in Fayoum University
Teaching Hospital. All EEGs were carried either under stan-
dard conditions or after sedative premedication as chloral
hydrate in noncooperative children. The EEGmachine param-
eters were adjusted before the record as follows: time constant
0.3 s; drawing speed 3.0 cm/s; and filter 75 Hz for EEG. The
EEG tracing was analyzed as regards background activity and
presence of generalized or focal epileptogenic discharges.
Genotyping
DNA purification All children underwent peripheral blood
sampling for genotype analyses. Two milliliters of blood was
collected in a tube containing ethylenediaminetetraacetate as an
anticoagulant for DNA extraction and stored at −20 °C. Ge-
nomic DNAwas isolated from peripheral blood leucocytes by
means of a genomic DNA purification kit according to manu-
facturer's instructions (Fermentas Life Sciences, Lithuania).
IL-1Ra and IL-1β-511 C/T genotypes were determined
as previously described (Zhang et al. 2007). Each polymer-
ase chain reaction (PCR) reaction was carried out with 50 ng
of genomic DNA, 20 pmol of each primer, 12.5 μl Master
Mix (Dream TaqTM, Green PCR Master Mix) (Fermentas
Life Sciences, Lithuania) in a total volume of 25 μl. IL-1Ra
genotyping was performed with the primer pair (forward, 5′-
CTC AGC AAC ACT CCT AT-3′, and reverse, 5′-TCC
TGG TCT GCA GGT AA-3′) (Bioneer, Korea) with initial
denaturation at 94 °C for 4 min followed by 32 cycles of
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94 °C for 1 min, 50 °C for 1 min, and 72 °C for 1 min with
final extension at 72 °C for 10 min using a PCR Thermal
Cycler (Thermo Hybaid, UK). PCR products were analyzed
by electrophoresis on a 1.5 % agarose gel stained with
ethidium bromide. Alleles 1–5 (IL1Ra 1–IL1Ra 5) were
detected according to their sizes relative to a 100-bp DNA
ladder: allele 1 (four repeats), 410 bp; allele 2 (two repeats),
240 bp; allele 3 (five repeats), 500 bp; allele 4 (three
repeats), 325 bp; and allele 5 (six repeats), 595 bp (Fig. 1).
IL-1β-511 C/T genotyping was performed with the primer
pair (forward, 5′-TGG CAT TGATCT GGT TCATC-3′, and
reverse, 5′-GTT TAG GAATCT TCC CAC TT-3′) (Bioneer,
Korea) with initial denaturation at 95 °C for 1 min followed by
30 cycles of 95 °C for 30 s, 55 °C for 30 s, and 72 °C for 30 s
with final extension at 70 °C for 7 min using a PCR Thermal
Cycler (ThermoHybaid, UK). PCR products were digested by
restriction endonuclease Aval (Promega) and visualized by
electrophoresis on a 3 % agarose gel stained with ethidium
bromide. Alleles were coded as follows: T, 304 bp, and C, 190
and 114 bp (Fig. 2).
Statistical analysis
Statistical analysis was performed using the Statistical Pack-
age for Social Science version 17 (Chicago, USA). Data
were subjected to Kolmogorov–Smirnov test to determine
the distribution and method of analysis. Normally distribut-
ed quantitative variables are presented as mean±SD and the
comparisons between groups were performed using Stu-
dent's t test. Skewed data are expressed as median (range).
Categorical variables are given as percentages. A chi-square
test was used to compare the sex and gene polymorphism
and each of consanguinity, frequency of seizures per year
(more than five attacks per year), and positive family history
of FSs. Genotype and allele distributions among cases and
controls were compared using odds ratios and 95 % confi-
dence interval. Allele frequencies were estimated by the
gene counting method and expressed as a percentage of
the total number of alleles. A p value of <0.05 was considered
to represent statistical significance.
Results
Twenty-two Egyptian children with FSs were recruited in
the study. Clinical characteristics of the patient group are
presented in Table 1.
The age of patients ranged from 12 months to 6 years,
while the age of onset of first febrile seizures ranged from 6
and 36 months of age (mean±SD 15.7±7.6 months). The
number of febrile seizures per year in the patient group
ranged from 2 to 8 with mean±SD (4.9±2.1). Of the 22
FSs cases, eight cases (36.4 %) had more than two attacks of
seizures in the same day. The average duration of the seiz-
ures was 6 min (3–20) (median; range).
Within normal EEG accounted for 14/22 (63.6 %), while
8/22 (36.4 %) had abnormal pattern in the form of either
generalized slowing of postictal record or focal and multi-
focal epileptogenic activity. Regarding the medications, 17
FS cases (77.3 %) received antiepileptic therapy in the form
of sodium valproate, while the remaining five cases (22.7 %)
did not receive any treatment.
The distribution of the IL-Ra and IL-1β-511 promoter
genotypes and allele frequencies in the patient group and
control group are shown in Tables 2 and 3. Genotype pro-
portions and allele frequencies for the IL-1Ra in both groups
were significantly different between FS cases and the con-
trol group. The most common genotype for IL-1Ra gene in
both groups was I/I. Allele I for IL-1Ra was associated with
febrile seizures. The IL-1Ra I/I homozygote was more fre-
quent in patients with FSs than in healthy controls (86.36 vs.
59.09 %, p<0.05). In addition, individuals homozygous for
the IL-1 Ra I/I genotype were more than twice as likely to
develop FSs as individuals heterozygous for the IL-1 Ra I/II
genotype (odds ratio (OR), 4.385; 95 % confidence interval
(CI), 0.993–19.356; p<0.05). IL-1Ra I/II genotype was
significantly associated with resistance to febrile seizures
(OR, 0.144; 95 % CI, 0.027–0.778; p<0.05).
There was no significant difference in the frequency of the
IL-1β-511 TT genotype (p>0.05) between the FS patients and
1               2                3
240 bp
410 bp
Fig. 1 Agarose gel electrophoresis of the IL-1Ra genotypes. Lane1
100 bp DNA marker. Lane 2 IL-1Ra I/I (410 bp). Lane 3 IL-1Ra I/II
(410 and 240 bp)
1              2              3              4
304 bp
190bp
114bp
Fig. 2 Agarose gel electrophoresis of the IL-1β-511 genotypes. Lane
1 CT genotype (304, 190, and 114 bp). Lane 2 CC genotype (190 and
114 bp). Lane 3 TT genotype (304 bp). Lane 4 100 bp DNA marker
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controls. The percentage of CC genotype was more in the FS
patients compared to the control group, while the percentage
of the CT genotype was more in the control group compared
to the FS patients. The IL-1β-511 CTand CC genotypes were
associated with an odds ratio of 0.183 (95 % CI, 0.047–0.729)
and 5.714 (95 % CI, 1.051–31.072), respectively, for FSs. FS
patients with IL-1β-511 CC genotypeweremore than twice as
likely to develop FSs. The presence of the C allele at IL-1β-
511 increased the risk of FSs by more than twofold (odds
ratio, 5.50; 95 % CI, 2.267–13.345).
There was a significant relationship between the CC and
CT genotypes and the presence of positive consanguinity
among the parents of our cases (p<0.001). And finally, we
found a significant relationship between IL-1Ra I/I genotype
and the frequency of seizures per year for those with more
than five attacks per year (p<0.05; Table 4).
Discussion
Although an association between FSs and IL-1 β production
has long been suspected, conflicting results have been
reported (Tsai et al. 2002). In the present study, we investi-
gated the role of IL-1β-511 C/T and IL-1Ra gene polymor-
phisms as risk factors for FSs.
The mean age at initial seizure was 15.7±7.6 months in the
patient group, which is similar to age reported for simple FSs
(19.7±11.2 months) in a previous study carried by Serdaroglu
et al. (2009). A positive family history was found in 27.3 % of
the FS children which agrees with Matsuo et al. (2006) who
reported that a positive family history for FSs can be elicited in
25–40 % of patients with FSs.
Concerning the distribution of IL1Ra genotypes among our
studied groups, the results of the present study show that the
IL-1Ra allele I is associated with higher susceptibility to FSs
and this is in agreement with the results of Tsai et al. (2002)
Table 1 Clinical characteristics of febrile seizures patients and healthy
control subjects
Characteristics Febrile seizures
(n022)
Control subjects
(n022)
Age (years; mean±SD) 2.62±1.15 11.5±2.1
Gender
Male, no. (%) 18 (81.82) 16 (72.73)
Female, no. (%) 4 (18.18) 6 (27.27)
Age of onset of first febrile
seizure, months (mean±SD)
15.7±7.6 –
Age of presentation, months
(mean±SD)
31.3±13.8
Febrile seizure, number per year
(mean±SD)
4.9±2.1 –
Duration of febrile seizures,
minutes, median (range)
6 (3–20) –
Family history of febrile
seizures, no. (%)
6/22 (27.3) –
Sporadic, no. (%) 16/22 (72.7)
History of consanguinity, no. (%) 8/22 (36.4) –
Simple febrile seizures, no. (%) 4/22(18.2) –
Complex febrile seizures, no. (%) 18/22 (81.8) –
Type of febrile seizures
GTCs, no. (%) 19/22 (86.4)
Focal, no. (%) 2/22 (9.1) –
Atonic, no. (%) 1/22 (4.5)
EEG findings
Normal, no. (%) 14/22 (63.6)
Abnormal, no. (%) 8/22 (36.4) –
On treatment, no. (%) 17/22 (77.3) –
GTCs generalized tonic–clonic seizures, EEG electroencephalography,
SD standard deviation, no. number
Table 2 Genotype and allele frequencies of IL-1Ra gene polymor-
phism in febrile seizure patients compared to the control group
Febrile seizure
cases (n022)
Controls
(n022)
p value
IL-1Ra I/I genotype,
no. (%)
19/22 13/22 <0.05
(86.36 %) (59.09 %)
IL-1Ra I/II genotype,
no. (%)
3/22 9/22 <0.05
(13.64 %) (40.91 %)
I allele, no. (%) 41 35 <0.05
(93.18 %) (79.55 %)
II allele, no. (%) 3 9 <0.05
(6.82 %) (20.45 %)
p values for comparison of genotypes between cases and controls were
calculated by means of a 2×2 contingency chi-square
no. number, IL-1Ra interleukin-1 receptor antagonist
Table 3 Genotype and allele frequencies of IL-1β-511 gene polymor-
phism in febrile seizure patients compared to the control group
Febrile seizure
cases (n022)
Controls
(n022)
p value
CC genotype, no. (%) 8/22 2/22 <0.05
36.36 % 9.09 %
CT genotype, no. (%) 10/22 18/22 <0.05
45.46 % 81.82 %
TT genotype, no. (%) 4/22 2/22 >0.05
18.18 % 9.09 %
C allele, no. (%) 26 22 <0.001
59.09 % 50 %
T allele, no. (%) 18 22 <0.001
40.91 % 50 %
p values for comparison of genotypes between cases and controls were
calculated by means of a 2×2 contingency chi-square
no. number, IL-1β interleukin 1-beta
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and Chou et al. (2010). This is in contrast to the results
of Serdaroglu et al. (2009) who reported that the fre-
quency of both the IL1RaII/II genotype and the IL1RaII
allele was significantly higher in the FS patient group than
the controls.
Concerning the distribution of IL-1β-511 genotypes
among our studied groups, our results show that the distri-
bution of the IL-1β-511 TT genotype showed no significant
difference between FS patients and controls. In agreement
with the present findings, Tilgen et al. (2002), Haspolat et al.
(2005), and Chou et al. (2010) reported no significant asso-
ciation between FSs in the studied German, Turkish, and
Taiwanese populations, respectively, and IL-1β-511 poly-
morphism, indicating that it is not useful in predicting the
susceptibility to FSs. In contrast to the present findings,
Virta et al. (2002) and Serdaroglu et al. (2009) concluded
that the distribution of IL-1β-511 genotypes and the allele
frequency differed significantly between FS patients and the
control group in the Finish and Turkish studied groups,
respectively. They stated that the TT genotype was signifi-
cantly more common in the patient group than in the control
group. Virta et al. (2002) concluded that the Tallele frequency
was significantly higher in children with FSs. The inconsistent
results may be attributed to different illness classification,
ethnic variation, and local environmental factors. Interaction
between environment and gene may play an important role
and the inconsistent results may be due to the fact that not all
studies listed the inclusion criteria of cases; in some studies,
cases were matched to controls according to age, sex, ethnic-
ity, and so on, but others were not (Wu et al. 2012).
Our results show that FS patients with IL-1β-511 CC
genotype were more than twice as likely to develop FSs.
Santtila et al. (1998) reported that IL1Ra allele II strongly
increased in vitro production of IL1 β, regardless of the
presence or absence of IL-1β-511. They stated that IL-1β-
511 T allele had a slight but nonsignificant elevated capacity
to produce IL-1β in vitro. The results of Tsai et al. (2002)
suggested that the IL-1Ra allele II as well as the increased
production of IL-1β might play a role in preventing febrile
convulsions. Addas-Carvalho et al. (2004) stated that IL-
1β-511 T polymorphism enhanced IL-1β production. From
the present results, which showed that patients with IL-1Ra
allele I and IL-1β-511 CC genotype were more than twice
as likely to develop FSs, and those of previous studies, we
can speculate that if IL1Ra allele II and IL-1β-511 T allele
increase the IL-1β production, therefore increased IL-1β
levels prevent febrile convulsions. In agreement, Matsou et
al. (2006) had documented significantly increased IL-1Ra/
IL-1 β ratios among FS patients.
Wen et al. (2006) concluded that IL-1β-511 SNP leads to
an increased expression of the encoded protein as a result of
enhanced gene transcription. However, this activity seems to
be dependent on the haplotype context of the promoterTa
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region of IL-1β. Chen et al. (2006) demonstrated that
the IL-1β-511 T allele strongly enhanced the transcrip-
tion of the IL-1β gene in the context of the IL-1β-31 C
allele. These findings highlight the importance of under-
standing the haplotype structure of populations used for
genetic studies (Kauffman et al. 2008).
Chou et al. (2010) suggested that the balance be-
tween IL-1β and IL-1Ra during seizures plays a signif-
icant role in altering neuronal network excitability, thus
affecting the maintenance and spread of seizures. How-
ever, several studies speculated that IL-1β may play a
role in FSs by direct action on ionic currents or indirectly by
enhancing extracellular glutamate concentrations or reducing
GABAA receptor function (Zeise et al. 1997; Kamikawa et al.
1998; Wang et al. 2000).
In the present study, there was no statistically signif-
icant relationship between IL-1Ra and IL-1β-511 geno-
types and the presence of family history of FSs among
the studied group of patients. On the other hand, there
was a significant relationship between IL-1β-511 CC
and CT genotypes and the presence of positive consan-
guinity among the parents of our patients that may
suggest the presence of genetic factors. This is in con-
trast to the results that showed that the frequency of IL-
1β-511 T allele was significantly increased in sporadic
simple FS patients as compared with controls (Kira et
al. 2010). We found a significant relationship between
IL-1Ra I/I with the frequency of seizures per year for those
with more than five attacks per year suggesting that the
increased frequency may reveal the pivotal role of ge-
netic factors. There was no significant association between
IL-1Ra and IL-1β-511 genotypes and seizure duration and
this is in agreement with the results of Serdaroglu et al.
(2009).
Historical records show that the Egyptian population is
one that has undergone genetic admixture and racial mixing,
which created a heavily mixed population of modern Egyp-
tians including several ethnic groups such as Bedouins,
Peasants, Nubians, Berbers, and Urbanites (Shahin et al.
2011). Fayoum is a city in middle Egypt situated 130 km
southwest of Cairo and all the participants were chosen from
this town to allow for homogeneity. To our knowledge, this
is the first study investigating the contribution of IL-1Ra and
IL-1β-511 gene polymorphisms in the pathogenesis of FSs
in a group of Egyptian children.
It is necessary to perform a large-scale, multicenter,
case–control study before setting a final statement on the
role of IL-1β and IL-1Ra gene polymorphisms in FSs.
However, our present study provides evidence of asso-
ciation between the IL-1Ra I/I and IL-1β-511 CC gen-
otypes and FSs pointing to the role of these loci in contribution
to FS susceptibility in the studied group of Egyptian patients
from Fayoum City.
Conclusion
In conclusion, our study suggests that IL-1Ra I/I and IL-1β-
511 CC genotypes are positively associated with FSs. They
may be used as useful markers for predicting susceptibility to
FSs. In contrast, FSs are not associated with IL-1β-511 TT
genotype. These data suggest that cytokine genes may act as
enhancers or attenuators of FS susceptibility. If so, there may
be a potential role for therapy targeting cytokines as a novel
therapeutic strategy to prevent or limit FSs or subsequent
epileptogenesis in the vulnerable, developing nervous system
of children. Furthermore, the impact of other cytokine poly-
morphisms on the development of FSs merits further study.
Limitations of the study
We performed our study on a small sample of FS patients from
Fayoum City. Indeed, the number of cases in almost all
previous studies was also small. Thus, we recommend a large,
multicenter, case–control study including thousands of cases
to confirm the association between the IL-1Ra I/I and IL-1β-
511 CC genotypes and FSs in the Egyptian population.
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